Aktis Oncology, Inc. (AKTS)

NASDAQ: AKTS · Real-Time Price · USD

19.55

+0.05 (0.26%)

At close: May 15, 2026, 4:00 PM EDT

19.58

+0.03 (0.15%)

Pre-market: May 18, 2026, 7:20 AM EDT

Aktis Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	1,081	-	-	-	-
Enterprise Value	553.77	0	0	0	0
Debt / Equity Ratio	0.02	0.05	0.04	0.11	0.01
Debt / EBITDA Ratio	-	-0.16	-0.24	-0.40	-0.09
Debt / FCF Ratio	-	-0.16	1.01	-0.40	-0.09
Net Debt / Equity Ratio	-1.04	1.47	3.25	1.82	6.60
Net Debt / EBITDA Ratio	-	2.98	5.65	2.51	6.57
Net Debt / FCF Ratio	-	2.92	-23.96	2.50	6.21
Asset Turnover	-	0.02	0.01	0	0
Quick Ratio	19.29	7.26	15.79	15.69	24.38
Current Ratio	19.49	7.37	15.98	16.07	25.11
Return on Equity (ROE)	-	-29.45%	-25.18%	-24.42%	-13.71%
Return on Assets (ROA)	-	-25.27%	-23.21%	-26.70%	-14.29%
Return on Invested Capital (ROIC)	-	-313.78%	-256.73%	-277.38%	-372.62%
Return on Capital Employed (ROCE)	-	-27.61%	-24.58%	-27.93%	-14.85%
Buyback Yield / Dilution	-1784.33%	-15.53%	-14.46%	-18.90%	-
Total Shareholder Return	-1784.33%	-15.53%	-14.46%	-18.90%	-

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q